Literature DB >> 16837297

Cell-mediated immunity in anorexia nervosa augmented lymphocyte transformation response to concanavalin A and lack of increased risk of infection.

O H Bentdal1, S S Frøland, S Larsen.   

Abstract

Cell-mediated immunity (CMI) was studied in 33 consecutively admitted patients with anorexia nervosa (AN) who had a mean weight loss of 30%. Clinical infections were not diagnosed in the patients. The acute phase reactant, C-reactive protein, was slightly elevated in only one patient, but was within the normal range in the remainder. The absolute number of T-lymphocytes in peripheral blood was significantly increased (p < 0.01) in the AN-patients compared to the control group while the number of granulocytes was reduced (p < 0.01). However, a significant negative correlation between the relative weight loss and the numbers of both total and T-lymphocytes in the AN-patients was established (p < 0.05). Mitogen stimulation of lymphocytes with phytohemagglutinin (PHA), poke-weed-mitogen (PWM) and concanavalin A (Con A) showed no reduction in the proliferative response in AN-patients compared to the control group. On the contrary, Con A transformation was significantly higher (p < 0.03) in the AN-patients. The lymphocyte response to PWM (p < 0.02) was, however, diminished in the patients with the most advanced weight loss compared to those with the least weight loss.

Entities:  

Year:  1989        PMID: 16837297     DOI: 10.1016/0261-5614(89)90035-6

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

1.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Impaired in vitro survival of monocytes from patients with HIV infection.

Authors:  F Müller; H Rollag; G Gaudernack; S S Frøland
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 3.  Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.

Authors:  Pashtoon M Kasi; Hussein A Tawbi; Chester V Oddis; Hrishikesh S Kulkarni
Journal:  Crit Care       Date:  2012-08-31       Impact factor: 9.097

Review 4.  Anorexia Nervosa and the Immune System-A Narrative Review.

Authors:  Dennis Gibson; Philip S Mehler
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.